Intimate Networking & In-depth Learning, Catered for BD&L Professionals.
Fierce's BD&L Summit brings together business development leaders from pharma, biotech, and the investment community to discuss how deals actually get done in today’s market. Across three days, sessions will focus on the dynamics of sourcing external innovation, evaluating assets, structuring partnerships, and navigating the legal, financial, and strategic factors that shape licensing and M&A decisions.
Attendees will hear real examples of partnerships and transactions—from successful collaborations to deals that went off track—along with candid insights into how big pharma approaches dealmaking. Sessions will unpack the motivations, priorities, and internal dynamics that shape decisions, while biotech leaders share practical lessons from deals that worked.
See Who's Already Registered...
Here's a sample of attendees from the Pharma Marketing Community:
Adventris Pharmaceuticals, Fractional CBO General Proximity
Ailux, Business Development Manager
Allogene Therapeutics, VP Corporate & Business Development
Amplity Inc., VP-New Client Partnerships
ANTA Biotech, CEO & Founder
Astellas Innovation Lab, SVP
Bausch and Lomb, Director Growth and Strategic Projects
Biocytogen, Deputy Director of BD- Licensing
Bostal LLC, CEO
Caribou Biosciences, VP of BD
Coherus Oncology, former EVP Corporate Development
Encoded Therapeutics, VP and Head of Intellectual Property
Eradivir Inc., CEO
Excalipoint Therapeutics, Co-founder, CFO & CBO
Gilead, Assoc. General Counsel IP Alliance Management and Due Diligence
GSK, Senior Director Business Development Search & Evaluation
Infinimmune, CEO & Founding Scientist
Johnson & Johnson, Head West N. America External Scientific Innovation
Juvena Therapeutics Inc, Sr. Corporate Development Manager
Lake Street Capital Markets, Managing Director
NovaQuest Capital Management, VP
Orca Bio, VP Head of Business Development
Origami Therapeutics Inc., President & CEO
Pacific Research Center, Sr. Director Search & Evaluation
Pacira Biosciences, Director Business & Corporate Development
PharmaEssentia, Director Corporate Strategy
Pilatus Biosciences, Co-Founder Board Member & CEO
Precision BioSciences Inc., Sr Manager Business Development
Roche, Global Head of Partnerships and Transactions
Silicon Valley Bank, Head of Relationship Management
Sofinnova Investments, Executive Partner
The Jackson Laboratory, VP Corporate Development
TopAlliance Biosciences, VP Business Development
Trethera, CEO
UCB Inc, Portfolio Innovation Peer to Peer Lead
Ventyx Biosciences, EVP NonClinical and Translational Research
Zai Lab, President and COO
The Fierce Pharma Engage Experience Gives You
BD&L Sessions You Can't Miss
Featured BD&L Speakers
Key Topics Covered for BD&L
Biotech Dealmaking in a Capital-Constrained Market
New Models for Strategic Partnerships
Global Licensing and Cross-Border Deals
Portfolio Strategy and Asset Prioritization
Financing Innovation Across the Development Lifecycle
Building Partnerships That Move Assets Forward
Let's work together!
Find out why Fierce Pharma Engage is the right show for you.